131I治疗初诊Graves甲亢并白细胞减少618例疗效分析

刘 曾1,徐细明1,刘国强2

欢迎访问《标记免疫分析与临床》官方网站!
标记免疫分析与临床 ›› 2015, Vol. 22 ›› Issue (9) : 897. DOI: 10.11748/bjmy.issn.1006-1703.2015.09.021
临床研究

131I治疗初诊Graves甲亢并白细胞减少618例疗效分析

    {{javascript:window.custom_author_cn_index=0;}}
  • {{article.zuoZhe_CN}}
作者信息 +

Curative Effect Analysis of 131I in the Treatment of 618 First Examined Graves’s Hyperthyroidism with WBC Loss Patients

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

本文亮点

{{article.keyPoints_cn}}

HeighLight

{{article.keyPoints_en}}

摘要

{{article.zhaiyao_cn}}

Abstract

{{article.zhaiyao_en}}

关键词

Key words

引用本文

导出引用
{{article.zuoZheCn_L}}. {{article.title_cn}}. {{journal.qiKanMingCheng_CN}}. 2015, 22(9): 897 https://doi.org/10.11748/bjmy.issn.1006-1703.2015.09.021
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2015, 22(9): 897 https://doi.org/10.11748/bjmy.issn.1006-1703.2015.09.021

参考文献

参考文献

{{article.reference}}

基金

版权

{{article.copyrightStatement_cn}}
{{article.copyrightLicense_cn}}

Accesses

Citation

Detail

段落导航
相关文章

/